Cargando…

Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines

INTRODUCTION: KRAS was one of the earliest human oncogenes to be described and is one of the most commonly mutated genes in different human cancers, including colorectal cancer. Despite KRAS mutants being known driver mutations, KRAS has proved difficult to target therapeutically, necessitating a co...

Descripción completa

Detalles Bibliográficos
Autores principales: Varshavi, Dorna, Varshavi, Dorsa, McCarthy, Nicola, Veselkov, Kirill, Keun, Hector C., Everett, Jeremy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616861/
https://www.ncbi.nlm.nih.gov/pubmed/34822010
http://dx.doi.org/10.1007/s11306-021-01852-w
_version_ 1784604420281991168
author Varshavi, Dorna
Varshavi, Dorsa
McCarthy, Nicola
Veselkov, Kirill
Keun, Hector C.
Everett, Jeremy R.
author_facet Varshavi, Dorna
Varshavi, Dorsa
McCarthy, Nicola
Veselkov, Kirill
Keun, Hector C.
Everett, Jeremy R.
author_sort Varshavi, Dorna
collection PubMed
description INTRODUCTION: KRAS was one of the earliest human oncogenes to be described and is one of the most commonly mutated genes in different human cancers, including colorectal cancer. Despite KRAS mutants being known driver mutations, KRAS has proved difficult to target therapeutically, necessitating a comprehensive understanding of the molecular mechanisms underlying KRAS-driven cellular transformation. OBJECTIVES: To investigate the metabolic signatures associated with single copy mutant KRAS in isogenic human colorectal cancer cells and to determine what metabolic pathways are affected. METHODS: Using NMR-based metabonomics, we compared wildtype (WT)-KRAS and mutant KRAS effects on cancer cell metabolism using metabolic profiling of the parental KRAS (G13D/+) HCT116 cell line and its isogenic, derivative cell lines KRAS (+/–) and KRAS (G13D/–). RESULTS: Mutation in the KRAS oncogene leads to a general metabolic remodelling to sustain growth and counter stress, including alterations in the metabolism of amino acids and enhanced glutathione biosynthesis. Additionally, we show that KRAS(G13D/+) and KRAS(G13D/−) cells have a distinct metabolic profile characterized by dysregulation of TCA cycle, up-regulation of glycolysis and glutathione metabolism pathway as well as increased glutamine uptake and acetate utilization. CONCLUSIONS: Our study showed the effect of a single point mutation in one KRAS allele and KRAS allele loss in an isogenic genetic background, hence avoiding confounding genetic factors. Metabolic differences among different KRAS mutations might play a role in their different responses to anticancer treatments and hence could be exploited as novel metabolic vulnerabilities to develop more effective therapies against oncogenic KRAS. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-021-01852-w.
format Online
Article
Text
id pubmed-8616861
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86168612021-12-01 Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Varshavi, Dorna Varshavi, Dorsa McCarthy, Nicola Veselkov, Kirill Keun, Hector C. Everett, Jeremy R. Metabolomics Original Article INTRODUCTION: KRAS was one of the earliest human oncogenes to be described and is one of the most commonly mutated genes in different human cancers, including colorectal cancer. Despite KRAS mutants being known driver mutations, KRAS has proved difficult to target therapeutically, necessitating a comprehensive understanding of the molecular mechanisms underlying KRAS-driven cellular transformation. OBJECTIVES: To investigate the metabolic signatures associated with single copy mutant KRAS in isogenic human colorectal cancer cells and to determine what metabolic pathways are affected. METHODS: Using NMR-based metabonomics, we compared wildtype (WT)-KRAS and mutant KRAS effects on cancer cell metabolism using metabolic profiling of the parental KRAS (G13D/+) HCT116 cell line and its isogenic, derivative cell lines KRAS (+/–) and KRAS (G13D/–). RESULTS: Mutation in the KRAS oncogene leads to a general metabolic remodelling to sustain growth and counter stress, including alterations in the metabolism of amino acids and enhanced glutathione biosynthesis. Additionally, we show that KRAS(G13D/+) and KRAS(G13D/−) cells have a distinct metabolic profile characterized by dysregulation of TCA cycle, up-regulation of glycolysis and glutathione metabolism pathway as well as increased glutamine uptake and acetate utilization. CONCLUSIONS: Our study showed the effect of a single point mutation in one KRAS allele and KRAS allele loss in an isogenic genetic background, hence avoiding confounding genetic factors. Metabolic differences among different KRAS mutations might play a role in their different responses to anticancer treatments and hence could be exploited as novel metabolic vulnerabilities to develop more effective therapies against oncogenic KRAS. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-021-01852-w. Springer US 2021-11-25 2021 /pmc/articles/PMC8616861/ /pubmed/34822010 http://dx.doi.org/10.1007/s11306-021-01852-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Varshavi, Dorna
Varshavi, Dorsa
McCarthy, Nicola
Veselkov, Kirill
Keun, Hector C.
Everett, Jeremy R.
Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
title Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
title_full Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
title_fullStr Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
title_full_unstemmed Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
title_short Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines
title_sort metabonomics study of the effects of single copy mutant kras in the presence or absence of wt allele using human hct116 isogenic cell lines
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616861/
https://www.ncbi.nlm.nih.gov/pubmed/34822010
http://dx.doi.org/10.1007/s11306-021-01852-w
work_keys_str_mv AT varshavidorna metabonomicsstudyoftheeffectsofsinglecopymutantkrasinthepresenceorabsenceofwtalleleusinghumanhct116isogeniccelllines
AT varshavidorsa metabonomicsstudyoftheeffectsofsinglecopymutantkrasinthepresenceorabsenceofwtalleleusinghumanhct116isogeniccelllines
AT mccarthynicola metabonomicsstudyoftheeffectsofsinglecopymutantkrasinthepresenceorabsenceofwtalleleusinghumanhct116isogeniccelllines
AT veselkovkirill metabonomicsstudyoftheeffectsofsinglecopymutantkrasinthepresenceorabsenceofwtalleleusinghumanhct116isogeniccelllines
AT keunhectorc metabonomicsstudyoftheeffectsofsinglecopymutantkrasinthepresenceorabsenceofwtalleleusinghumanhct116isogeniccelllines
AT everettjeremyr metabonomicsstudyoftheeffectsofsinglecopymutantkrasinthepresenceorabsenceofwtalleleusinghumanhct116isogeniccelllines